Format

Send to

Choose Destination
Ann Ist Super Sanita. 2013;49(1):73-8.DOI: 10.4415/ANN_13_01_12.

Advancing the science of cancer cost measurement: challenges and opportunities.

Author information

1
Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, Rome, Italy. silvia.francisci@iss.it

Abstract

OBJECTIVES:

Cancer accounts for a major proportion of national health expenditures, which are expected to increase in the future. This paper aims to identify major challenges with estimating cancer related costs, and discuss international comparisons, and recommendations for future research.

METHODS:

It starts from the experience of an international workshop aimed at comparing cancer burden evaluation methods, improving results comparability, discussing strengths and criticisms of different approaches.

RESULTS:

Three methodological themes necessary to inform the analysis are identified and discussed: data availability; costs definition; epidemiological measures.

CONCLUSIONS:

Cost evaluation is applied to cancer control interventions and is relevant for public health planners. Despite their complexity, international comparisons are fundamental to improve, generalize and extend cost evaluation to different contexts.

PMID:
23535133
DOI:
DOI: 10.4415/ANN_13_01_12
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Istituto Superiore di Sanita
Loading ...
Support Center